Teva announces increase of the maximum tender amount of its debt tender offer and increases to pool tender caps for pool 2 notes and pool 3 notes

Tel aviv, israel, may 22, 2025 (globe newswire) -- teva pharmaceutical industries ltd. (nyse and tase: teva) (“teva”) announced today that it is increasing the maximum tender amount of its tender offer previously announced on may 19, 2025 from $2.0 billion (equivalent) aggregate cash purchase price (exclusive of accrued and unpaid interest) to approximately $2.25 billion (equivalent) aggregate cash purchase price (exclusive of accrued and unpaid interest) (the “total maximum amount”).
TEVA Ratings Summary
TEVA Quant Ranking